Wire Stories
-
76.9KElpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of First-in-Class Anti-CD39xTGF-? Bispecific Antibody ES014
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.–(BUSINESS WIRE)–Elpiscience Biopharmaceuticals, Inc. (�Elpiscience�), a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies for...
-
30.4KHCLTech launches suite of technology solutions for 5G and beyond
NOIDA, India & BARCELONA, Spain–(BUSINESS WIRE)–#5G–HCLTech, a leading global technology company, launched a range of innovative technology solutions for the 5G ecosystem...
-
31.6KBeiGene Reports Fourth Quarter and Full Year 2022 Financial Results
Recorded product revenue of $339.0 million and $1.3 billion for the fourth quarter and full year, respectively, increasing 72.3% and 97.9% from...
-
29.8KNickel 28 Releases Ramu Q4 and Full Year 2022 Operating Performance
TORONTO–(BUSINESS WIRE)–$NKL #mining–Nickel 28 Capital Corp. (�Nickel 28� or the �Company�) (TSXV: NKL) (FSE: 3JC0) is pleased to provide an update on...
-
28.5KDr. Reddy’s Laboratories Announces Agreement to Acquire Mayne Pharma�s U.S. Generic Prescription Product Portfolio
HYDERABAD, India & BASEL, Switzerland & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #DRREDDY–Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy�s Laboratories Ltd. (BSE: 500124,...
-
27.9KBiocytogen�s Subsidiary Eucure Biopharma and Chipscreen Biosciences� Holding Subsidiary Chipscreen NewWay Biosciences Enter into Greater China License Agreement for Bispecific Antibody YH008
BEIJING–(BUSINESS WIRE)–#Biocytogen–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that its wholly owned subsidiary, Eucure (Beijing) Biopharma Co., Ltd. (�Eucure...
-
31.6KChina Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)
Neuboron develops an advanced in-hospital NeuPex AB-BNCT medical system for clinical use at XHH Research Center. XIAMEN, China–(BUSINESS WIRE)–Neuboron Medical Group (NMG),...
-
33.4KChina Autonomous Driving Algorithm Research Report 2023: Promoting Developments of an End-to-End Autonomous Driving Framework – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “China Autonomous Driving Algorithm Research Report, 2023” report has been added to ResearchAndMarkets.com’s offering. BEV Drives Algorithm Revolution, AI Large...
-
30.7KResearch Report on China’s Polyester Staple Fiber Export Industry, 2023-2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Polyester Staple Fiber Export 2023-2032” report has been added to ResearchAndMarkets.com’s offering. Polyester staple fiber is...
-
36.8KTech Mahindra Launches SANDSTORM, an Innovative Remote Network Monitoring and Smart Device Assurance Service for Telcos and Enterprises
Bringing all smart devices to Tech Mahindra�s home-grown automation platform to enhance customers� digital experience journey Tech Mahindra showcased SANDSTORM at Mobile...
To Top